The AstraZeneca (LSE:AZN) share price just dipped below £100 per share. The stock has seriously underperformed in recent months, falling from above £130 in August. So, let’s take a look at what’s ...

Berenberg Bank reissued a “buy” rating and set a £150 ($195.26) price objective on shares of AstraZeneca in a research report ...

AstraZeneca is scheduled to report results for the third ... illegal importation of cancer drugs and patient data collection. This could affect the share price sentiment for the coming months and ...

JPMorgan Chase & Co. reissued their overweight rating on shares of AstraZeneca (LON:AZN – Free Report) in a report issued on ...

The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

AstraZeneca.com. "AZN Share Price Movement." Bloomberg. “China Detains AstraZeneca Staff in Data, Drug-Import Probes." ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...

In a notice issued to the London Stock Exchange on the company’s share price movement, AstraZeneca (AZN) stated: “As a matter of ...